New York Medical Malpractice in 2026: The 2.5-Year SOL, Continuous Treatment, and Frye in a Daubert World

Verify it yourself — free, no login

See how AI medical-record review links every fact to the exact Bates page that proves it — click any citation and jump straight to the record.

See the 60-second demo →

By John Mahoney · Founder, MedLegal AI · May 18, 2026

New York med-mal practice has four moving parts that distinguish it from neighboring states: a 2.5-year statute of limitations under CPLR 214-a, the continuous treatment doctrine and Lavern's Law cancer-misdiagnosis discovery rule, the CPLR 3012-a certificate of merit, and a Frye reliability standard in a country that has largely moved to Daubert. The damages framework is plaintiff-favorable — no statutory non-economic damages cap, structured judgment rules under CPLR Articles 50-A and 50-B.

This is the 2026 working overview for plaintiff firms running New York med-mal — CPLR 214-a, continuous treatment, Frye, and the case-building posture that decides whether the case survives long enough to reach the substantive damages framework.

The 2.5-Year Statute of Limitations

CPLR 214-a sets the limitations period for a medical, dental, or podiatric malpractice action at two years and six months from the act, omission, or failure complained of, or last treatment when there is continuous treatment for the same illness, injury, or condition. For minors, CPLR 208 tolls the limitations period until the eighteenth birthday with a 10-year outer limit (extended in some categories).

Three structural features differentiate New York's framework:

  1. The 2.5-year period is longer than most states. Most med-mal jurisdictions run 1–2 years. New York's extra six months gives plaintiff firms working margin that PA, FL, and TX do not provide.
  2. Continuous treatment tolls the clock. The treatment must be for the same condition that gave rise to the malpractice claim — not merely the same physician for unrelated care. Borgia v. City of New York, 12 N.Y.2d 151 (1962), established the doctrine; subsequent decisions have refined what counts as continuous.
  3. Lavern's Law (2018) creates a discovery rule for cancer misdiagnosis. CPLR 214-a(b) allows up to 2.5 years from the date the plaintiff knew or reasonably should have known of the alleged act or omission, OR 7 years from the act or omission, whichever is earlier. The rule is limited to alleged negligent failure to diagnose cancer or malignant tumors.

Practical implication for case-building: New York's framework rewards record reviews that document the treatment timeline in granular detail. A continuous-treatment defense requires the record to show that the relationship between the patient and the alleged tortfeasor extended past the negligent act for the same condition. A Lavern's Law case requires the record to show when the symptoms presented, when imaging or labs flagged the abnormality, and when the patient was actually informed.

CPLR 3012-a: The Certificate of Merit

CPLR 3012-a requires the plaintiff in a medical, dental, or podiatric malpractice action to file with the complaint, or within 90 days thereafter, a certificate of merit stating that the attorney has reviewed the facts of the case, has consulted with at least one licensed physician (or dentist or podiatrist) the attorney reasonably believes is knowledgeable in the relevant issues, and concluded on the basis of that consultation that there is a reasonable basis for the commencement of the action.

The CPLR 3012-a certificate is less strict than Florida's Chapter 766 corroborating affidavit. The certifying physician need not be the same specialty as the defendant and need not submit a written affidavit. But the attorney's certification is sworn under penalty of frivolous-litigation sanctions. Bar discipline cases under DR 7-102 / RPC 3.1 have followed from CPLR 3012-a certifications later shown to lack a colorable factual basis.

Practical implication: the certification is real. The "reasonable belief" standard is what is signed by the attorney — and the supporting consultation should be documented in the engagement file. Plaintiff firms that treat CPLR 3012-a as a formality leave themselves exposed when a defense motion later reveals the case was filed without substantive expert support.

Frye in 2026: What Survives in New York's Reliability Framework

New York is one of the few remaining Frye jurisdictions. Frye v. United States, 293 F. 1013 (D.C. Cir. 1923), asks whether the expert's methodology has gained general acceptance in the relevant scientific community. People v. Wesley, 83 N.Y.2d 417 (1994), adopted the test. Parker v. Mobil Oil Corp., 7 N.Y.3d 434 (2006), and Cornell v. 360 W. 51st St. Realty, LLC, 22 N.Y.3d 762 (2014), refined what general acceptance requires — particularly in toxic-tort cases — and have analytical force in med-mal causation cases as well.

The 2026 reality is that New York's Frye framework has converged with federal Daubert in practice, even though the doctrinal labels differ. Defense motions in New York med-mal cases routinely cite Parker's requirement that the expert's specific-causation methodology has to be generally accepted in its application to the case at hand — not merely in its general validity. A causation opinion that combines accepted epidemiological data with accepted differential-diagnosis methodology but applies the combination to a specific case in a way that has not been published or peer-reviewed faces meaningful Frye exposure.

The plaintiff-side response is the same as the federal-court response: methodology articulated in named steps, each step mapped to peer-reviewed literature, differential-diagnosis analysis with ruled-in and ruled-out alternatives, expert qualifications mapped to the defendant's specialty.

The Damages Framework: No Cap, But Structured Judgment

New York does not have a statutory cap on non-economic damages in med-mal cases. The damages framework is governed by CPLR Articles 50-A (medical, dental, and podiatric malpractice) and 50-B (general tort) — the structured-judgment rules that convert lump-sum verdicts into periodic payments for future damages above specified thresholds.

The interaction between structured judgment and case economics is non-obvious. A jury verdict for future damages above the threshold is paid out over the plaintiff's life expectancy (with present-value adjustments) rather than in a lump sum. The plaintiff firm's contingency fee is calculated on the present value of the structured stream, not the gross verdict number. Cases that look attractive on gross verdict numbers can be less attractive after Article 50-A is applied.

Practical implication for case selection: New York med-mal cases reward firms that model the structured-judgment outcome at intake, not just the gross damages exposure. A plaintiff firm running New York cases without a structured-judgment-aware damages model is selecting cases on the wrong number.

How a Daubert/Frye Workup Tool Helps in New York

MedLegal AI's Daubert/Frye workup tool builds plaintiff expert reports to the New York standard: methodology mapped to peer-reviewed literature with general-acceptance documentation, alternative-cause analysis ruled in and ruled out with record citations, expert qualifications mapped to the defendant's specialty, and specific-causation analysis aligned to Parker's requirement. The tool flags reports that rely on personal experience without published support, methodology with analytical gaps, and qualifications that don't match the defendant's specialty. It maintains a state-specific precedent library that includes Wesley, Parker, Cornell, the continuous treatment doctrine line, and Lavern's Law mechanics — so the case posture can be aligned to the gatekeeping standard the trial court will apply.

For the damages side, MedLegal AI's damages calculator projects damages under the CPLR 50-A structured-judgment framework, so case-selection economics can be modeled at intake with the structured-payout downside built in.

You can run a free reliability workup on your expert here. Three minutes, no credit card.

Bottom Line

New York med-mal practice in 2026 has the longest working limitations period in plaintiff-friendly territory, no statutory damages cap, and a Frye reliability framework that functions like federal Daubert in practice. The cases that work in this environment are continuous-treatment-aware, CPLR 3012-a documented at engagement, Parker-grade in their expert reports, and CPLR 50-A modeled at intake. Firms that build the procedural and expert posture cleanly capture an unusually plaintiff-favorable damages framework. Firms that don't, lose to Frye exclusion at the trial court level and never see the substantive case.

Run a free reliability workup on your expert.


MedLegal AI is software, not a law firm. We do not provide legal advice. All AI-generated outputs require independent review by a licensed attorney.

Run a free Daubert workup on your expert

Six-pattern audit on a sample case in 90 seconds. No credit card.

Try the free Daubert workup →
MedLegal AI is software, not a law firm. We do not provide legal advice and no attorney-client relationship is created by use of this service. All outputs are AI-generated and must be independently reviewed by a licensed attorney before use in any legal proceeding, expert report, or client communication.
See the AI cite its source — no login
Most legal AI is wrong 17–33% of the time. Watch MedLegal AI pin every finding to the exact record page — click any citation and it jumps to the line that proves it.
Watch the 30-second demo →